PMID: 8599863Jan 1, 1996Paper

High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model

Cancer Chemotherapy and Pharmacology
E SmelandJ Aarbakke

Abstract

To elucidate mechanisms for methotrexate (MTX)-induced renal and hepatic toxicity, we investigated the acute effects of bolus plus continuous infusion of up to 0.4 g/kg 7-hydroxymethotrexate (7-OH-MTX) in the rat. We demonstrate for the first time in any species the occurrence of acute lethal toxicity within a few hours after 7-OH-MTX administration. Serum concentrations of 7-OH-MTX measured at the time of death were 1.4 mM (mean), about one-half of those achieved in some patients after infusion of high-dose MTX (HD-MTX) in the clinic. The data suggest an approximate LD50 (the dose lethal to 50% of the study population) of 0.3 g/kg and a steep dose/lethality curve for 7-OH-MTX. Moreover, acute renal and hepatic toxicity occurred as evidenced by severe morphological findings and increased serum levels of creatinine and liver transaminases. In all rats subjected to continuous infusion of 7-OH-MTX, yellow microscopic precipitations were apparent in the kidney tubules. Crystallization was also seen in bile ducts of the liver in some of the rats. These results further support that the formation of 7-OH-MTX is disadvantageous and that reported attempts to prevent its formation during MTX treatment are warranted.

References

Jul 1, 1978·Archives of Internal Medicine·S AhmadW A Bleyer
Aug 1, 1991·Pharmacology & Toxicology·R M BremnesJ Aarbakke
Aug 1, 1991·Investigational New Drugs·J L GremM C Christian
Jun 1, 1990·Arthritis and Rheumatism·B NuernbergD E Furst
Jan 1, 1989·Cancer Chemotherapy and Pharmacology·A N StarkS J Proctor
Jan 1, 1989·European Journal of Clinical Pharmacology·G DerayC Jacobs
Dec 1, 1988·Arthritis and Rheumatism·D J BjorkmanK G Tolman
Dec 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S P Ackland, R L Schilsky
Jan 1, 1988·Cancer Chemotherapy and Pharmacology·P PriceH J Bloom
Nov 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F Ries, J Klastersky
Jan 1, 1987·Annals of Clinical Biochemistry·P G Riches, J Kohn
Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·R ErttmannG Landbeck
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·R ErttmannG Landbeck
May 1, 1966·Biochemical Pharmacology·D G JohnsJ R Bertino
Apr 15, 1984·Biochemical Pharmacology·J J McGuireJ R Bertino
Jan 1, 1984·Pharmacology & Therapeutics·C Fleck, H Bräunlich
Sep 1, 1984·British Journal of Cancer·J M Gaukroger, L Wilson
Jan 1, 1983·Oncology·H Breithaupt, E Küenzlen
Apr 1, 1980·Cancer Letters·J LankelmaF Ramaekers
Aug 1, 1994·Journal of Internal Medicine·A FabbriG Marchesini
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·E SmelandJ Aarbakke
Aug 1, 1987·Journal of Pharmaceutical Sciences·M I DawsonF M Sirotnak

❮ Previous
Next ❯

Citations

May 21, 1999·Comparative Biochemistry and Physiology. Part C, Pharmacology, Toxicology & Endocrinology·S KitamuraS Ohta
Oct 8, 2013·Annals of Hematology·Anna BertramBernhard M W Schmidt
May 13, 2004·Cancer·Brigitte C WidemannPeter C Adamson
Jul 19, 2005·Pediatric Blood & Cancer·Marika GrönroosGianni Celsi
Jun 29, 2011·British Journal of Clinical Pharmacology·Laila HolmboeKirsten Sundby Hall
Feb 25, 2015·Renal Failure·Durrin Ozlem Dabak, Nevin Kocaman
Jan 16, 2007·Drug Metabolism and Pharmacokinetics·Aya MoriyasuShigeyuki Kitamura
Mar 5, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Rachel D CrouchJ Scott Daniels
Dec 29, 2000·Pediatric Hematology and Oncology·O M FuskevågJ Aarbakke
Jun 7, 2018·BMJ Case Reports·Robin George ManappallilIllolil Kuniyil Biju
Aug 27, 2005·Neurosurgical Focus·Daniel R PieperIan T Jackson
Jun 24, 2006·The Oncologist·Brigitte C Widemann, Peter C Adamson
Dec 1, 2009·Journal of Breath Research·Hany H EzzeldinRobert B Diasio
Jan 9, 2020·Acta Pharmacologica Sinica·Lei ZhouXiao-Yan Chen
Dec 16, 2004·Journal of Neurosurgery·Fady T CharbelMarlyn E Clark
Oct 6, 2020·Frontiers in Physiology·Zhibo GaiMichele Visentin
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria L H VlamingAlfred H Schinkel
Jul 11, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ayman M MahmoudAhmed A Allam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.